About the Company
We do not have any company description for Inhibikase Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. (IKT) Upgraded to Buy: What Does ... - Nasdaq
Investors might want to bet on Inhibikase Therapeutics, Inc. (IKT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in ...
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing ...
Inhibikase Therapeutics Reports Q2 2025 Financial Results
Inhibikase Therapeutics ( ($IKT) ) just unveiled an announcement. On August 14, 2025, Inhibikase Therapeutics announced its financial results for ...
Inhibikase Therapeutics, Inc. (IKT) CEO Dr. Milton Werner on Q4 2021 ...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2021 Results Conference Call April 1, 2022 8:00 AM ETCompany ParticipantsAlexander Lobo - Stern Investor ...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript March 28, 2024 Inhibikase Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of ...
Inhibikase Therapeutics Inc News (IKT) - Investing.com
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the ...
Inhibikase Therapeutics, Inc. Announces Pricing of its Initial Public ...
ATLANTA, Dec. 22, 2020 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that ...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call ...
Published on April 2, 2024 at 10:25 am by Insider Monkey Transcripts in News, Transcripts Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q4 2023 Earnings Call Transcript March 28, 2024 ...
Inhibikase Therapeutics, Inc. (IKT) Q4 2022 Earnings Call Transcript
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Conference Call April 3, 2023 8:00 AM ETCompany ParticipantsAlex Lobo - Stern Investor ...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call ...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript Published on April 7, 2023 at 10:25 pm by Insider Monkey Transcripts in News, Transcripts ...
Similar Companies
Loading the latest forecasts...